Gene · 3205
Papers4,255
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 4,255
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Long Noncoding RNA PCGEM1 Facilitates Tumor Growth and Metastasis of Osteosarcoma by Sponging miR-433-3p and Targeting OMA1. | Orthop Surg | 2023 | 36782343 | PubTator, text mining | PubMed |
| Long Non-Coding RNAs as Novel Targets for Phytochemicals to Cease Cancer Metastasis. | Molecules | 2023 | 36770654 | PubTator, text mining | PubMed |
| The Tumorigenic Role of Circular RNA-MicroRNA Axis in Cancer. | Int J Mol Sci | 2023 | 36769372 | PubTator, text mining | PubMed |
| DNA Methylation as a Diagnostic, Prognostic, and Predictive Biomarker in Head and Neck Cancer. | Int J Mol Sci | 2023 | 36769317 | PubTator, text mining | PubMed |
| The Intricate Role of Non-Coding RNAs in Sepsis-Associated Disseminated Intravascular Coagulation. | Int J Mol Sci | 2023 | 36768905 | PubTator, text mining | PubMed |
| Liquid Biopsy for Lung Cancer: Up-to-Date and Perspectives for Screening Programs. | Int J Mol Sci | 2023 | 36768828 | PubTator, text mining | PubMed |
| Taspase1 Facilitates Topoisomerase IIβ-Mediated DNA Double-Strand Breaks Driving Estrogen-Induced Transcription. | Cells | 2023 | 36766705 | PubTator, text mining | PubMed |
| Genetics and RNA Regulation of Uveal Melanoma. | Cancers (Basel) | 2023 | 36765733 | PubTator, text mining | PubMed |
| Molecular Mechanisms in Murine Syngeneic Leukemia Stem Cells. | Cancers (Basel) | 2023 | 36765677 | PubTator, text mining | PubMed |
| Diagnostic Performance of Biomarkers for Bladder Cancer Detection Suitable for Community and Primary Care Settings: A Systematic Review and Meta-Analysis. | Cancers (Basel) | 2023 | 36765672 | PubTator, text mining | PubMed |
| A Novel Methylation Marker NRN1 plus TERT and FGFR3 Mutation Using Urine Sediment Enables the Detection of Urothelial Bladder Carcinoma. | Cancers (Basel) | 2023 | 36765573 | PubTator, text mining | PubMed |
| Brain Invasion and Trends in Molecular Research on Meningioma. | Brain Tumor Res Treat | 2023 | 36762808 | PubTator, text mining | PubMed |
| MORF and MOZ acetyltransferases target unmethylated CpG islands through the winged helix domain. | Nat Commun | 2023 | 36754959 | PubTator, text mining | PubMed |
| Expression and Predictive Significance of FHL1 and SLIT3 in Surgically Resected Lung Adenocarcinoma. | Comb Chem High Throughput Screen | 2023 | 36752296 | PubTator, text mining | PubMed |
| Single-cell transcriptome profiling of human HSCs during development: new insights into HSC ontogeny. | Signal Transduct Target Ther | 2023 | 36746910 | PubTator, text mining | PubMed |
| A potential area of use for immune checkpoint inhibitors: Targeting bone marrow microenvironment in acute myeloid leukemia. | Front Immunol | 2023 | 36742324 | PubTator, text mining | PubMed |
| Genetic and phenotypic continuum of HOXA genes: A case with double HOXA9/HOXA13 mutations. | Mol Med Rep | 2023 | 36734258 | PubTator, text mining | PubMed |
| Circular RNA SMARCA5 inhibits cholangiocarcinoma via microRNA-95-3p/tumor necrosis factor receptor associated factor 3 axis. | Anticancer Drugs | 2023 | 36727735 | PubTator, text mining | PubMed |
| Inhibition of menin, BCL-2, and FLT3 combined with a hypomethylating agent cures NPM1/FLT3-ITD/-TKD mutant acute myeloid leukemia in a patient-derived xenograft model. | Haematologica | 2023 | 36727398 | PubTator, text mining | PubMed |
Evaluation of differentially expressed genes during replication using gene expression landscape of monkeypox-infected MK2 cells: A bioinformatics and systems biology approach to understanding the genomic pattern of viral replication. | J Infect Public Health | 2023 | 36724696 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3205/papers?page=27